About Index Trending news
Analyze
Pricing
PULMOCIDE LIMITED

PULMOCIDE LIMITED

Work at PULMOCIDE LIMITED? Add yourself to this profile

PULMOCIDE LIMITED

Pulmocide is focused on the development of inhaled medicines for the treatmentof viral and fungal infections of the respiratory tract.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in London

Reuters Reuters Blockchain Blockchain BBC BBC Vodafone Vodafone SwiftKey SwiftKey Ubuntu Ubuntu Virgin Virgin Volkswagen Volkswagen Charlie Charlie Deliveroo Deliveroo

Companies in the same industry

Coronado Biosciences Coronado Biosciences Surgical Care Affiliates Surgical Care Affiliates Amicus Therapeutics Amicus Therapeutics Ranomics Ranomics Fibrocell Science Fibrocell Science Beijing Allcure Medical Technology Beijing Allcure Medical Technology TRACON Pharmaceuticals TRACON Pharmaceuticals Avro Life Science Avro Life Science SkyQuest Technology Consulting Private Limited SkyQuest Technology Consulting Private Limited Supercraft3D Supercraft3D

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Add round
20 Mar 2017
$30,000,000
Venture capital (Series B)
SV Life Sciences, F-Prime Capital Partners, Johnson & Johnson, +2

British biotech Pulmocide raises £24m in bid to find treatment for deadly lung diseases

The Telegraph
+1
26 Nov 2013
$27,541,217
Venture capital (Series A)